[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337432-105":59,"doc-detail-337432-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","novel-insights-on-genetics-and-epigenetics-as-clinical-targets-for-paediatric-astrocytoma","Novel insights on genetics and epigenetics as clinical targets for paediatric astrocytoma","","Paediatric and adult astrocytomas show distinct biology, explaining why adult treatments often fail in children and may cause adverse long-term health effects. Integrative omics studies demonstrate that pathology and core molecular features differ markedly and cannot be inferred from adult disease. Using next-generation sequencing and epigenome-wide profiling, recent advances reveal canonical mutations shaped by tumour location and age of onset, including recurrent histone H3 alterations in high-grade tumours. This review synthesizes updates on classification, epidemiology, pathogenesis, clinical management and ongoing trials, emphasizing genetic and epigenetic alterations as diagnostic biomarkers and therapeutic targets.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/novel-insights-on-genetics-and-epigenetics-as-clinical-targets-for-paediatric-astrocytoma/337432/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/novel-insights-on-genetics-and-epigenetics-as-clinical-targets-for-paediatric-astrocytoma/337432.png","ImageObject",300,407,{"name":92,"@type":93},"Himbo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are adult astrocytoma treatments less effective for children with the same cancer type?","Question",{"text":112,"@type":113},"Paediatric astrocytomas differ substantially in pathology and fundamental molecular characteristics, so adult-derived clinical approaches do not translate well. These differences contribute to reduced effectiveness and potential long-term adverse health concerns.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What technologies enabled recent advances in understanding paediatric astrocytoma genetics and epigenetics?",{"text":117,"@type":113},"Next-generation sequencing and epigenome-wide profiling supported the identification of canonical mutations and epigenetic dysregulation. These methods also clarified how mutations vary by tumour location and age of onset.",{"name":119,"@type":110,"acceptedAnswer":120},"Which genetic/epigenetic changes are highlighted as key hallmarks or driver events?",{"text":121,"@type":113},"Recurrent DNA methylation and histone mutations are emphasized as hallmarks of paediatric astrocytoma oncogenesis. Driver alterations include recurrent histone H3 mutations in high-grade tumours.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337432,1790195415,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","DOI: 10.1002/ctm2.1560  \nREVIEW  \nNovel insights on genetics and epigenetics as clinical targets for paediatric astrocytoma  \nDonaA. Johns1  Richard J. Williams1, 2, 3  Craig M. Smith1,2 Pavani P. Nadaminti4  Rasika M. Samarasinghe1, 2   \n1 School of Medicine, Deakin University, Geelong, Victoria, Australia  \n2 Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Victoria, Australia  \n3The Graeme Clark Institute, The University of Melbourne, Melbourne, VIC, Australia  \n4 School of Agriculture, Food and Ecosystem Sciences, Faculty of Science, The University of Melbourne, Parkville, Melbourne, Victoria, Australia  \nCorrespondence  \nRasikaM. Samarasinghe, School of Medicine, Deakin University, Geelong, Victoria 3220, Australia. [Email:](Email: r.samarasinghe@deakin.edu.au)[ r.samarasinghe@deakin.edu.au](Email: r.samarasinghe@deakin.edu.au)  \nGraphical Abstract  \n∙ Alterations in genetics, particularly epigenetic biomarkers provide significant insights into the aetiology, diagnosis, prognosis and therapeutic strategies for paediatric astrocytomas.  \n∙ Recurrent DNA methylation and histone mutations are hallmarks of astrocytoma oncogenesis in paediatrics.  \n∙ Clinically targeting these markers have shown efficacy in preclinical and clinical trials, providing new treatment options for paediatric cancer patients.  \nClin. Transl. Med. 2024;14:e1560 .  \n[https://doi.org/10.1002/ctm2.1560](https://doi.org/10.1002/ctm2.1560)  \n[wileyonlinelibrary.com/journal/ctm2](wileyonlinelibrary.com/journal/ctm2)  \nDOI: 10.1002/ctm2.1560  \nREVIEW  \nNovel insights on genetics and epigenetics as clinical targets for paediatric astrocytoma  \nDonaA. Johns1  Richard J. Williams1, 2, 3  Craig M. Smith1,2 Pavani P. Nadaminti4  Rasika M. Samarasinghe1, 2   \n1 School of Medicine, Deakin University, Geelong, Victoria, Australia  \n2 Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Victoria, Australia  \n3The Graeme Clark Institute, The University of Melbourne, Melbourne, VIC, Australia  \n4 School of Agriculture, Food and Ecosystem Sciences, Faculty of Science, The University of Melbourne, Parkville, Melbourne, Victoria, Australia  \nCorrespondence  \nRasika M. Samarasinghe, School of Medicine, Deakin University, Geelong, Victoria 3220, Australia.  \nEmail: [r.samarasinghe@deakin.edu.au](r.samarasinghe@deakin.edu.au)  \nFunding information  \nDeakin University Postgraduate Research Scholarship  \nAbstract  \nPaediatric and adult astrocytomas are notably different, where clinical treatments used for adults are not as effective on children with the same form of cancer and these treatments lead to adverse long-term health concerns. Integrative omics-based studies have shown the pathology and fundamental molecular characteristics differ significantly and cannot be extrapolated from the more widely studied adult disease. Recent clinical advances in our understanding of paediatric astrocytomas, with the aid of next-generation sequencing and epigenome-wide profiling, have led to the identification of key canonical mutations that vary based on the tumour location and age of onset. These driver mutations, in particular the identification of the recurrent histone H3 mutations in high-grade tumours, have confirmed the important role epigenetic dysregulations play in cancer progression. This review summarises the current updates of the classification, epidemiology, pathogenesis and clinical management of paediatric astrocytoma based on their grades and the ongoing clinical trials. It also provides novel insights on genetic and epigenetic alterations as diagnostic biomarkers, highlighting the potential of targeting these pathways as therapeutics for this devastating childhood cancer.  \nKEYWORDS  \nepigenetics, gliomas, methylation, paediatric astrocytoma  \n1  INTRODUCTION  \nAstrocytomas are the most common and lethal forms of glioma that affect children. The","cbCaiiAPGGCjVwLB","https://ap.wps.com/l/cbCaiiAPGGCjVwLB","pdf",3331696,25,"English","# Introduction\n## Paediatric astrocytoma grades and molecular features\n## Classification and clinical management\n## Genetic and epigenetic alterations as biomarkers and therapeutic targets\n## Ongoing clinical trials","[{\"question\":\"Why are adult astrocytoma treatments less effective for children with the same cancer type?\",\"answer\":\"Paediatric astrocytomas differ substantially in pathology and fundamental molecular characteristics, so adult-derived clinical approaches do not translate well. These differences contribute to reduced effectiveness and potential long-term adverse health concerns.\"},{\"question\":\"What technologies enabled recent advances in understanding paediatric astrocytoma genetics and epigenetics?\",\"answer\":\"Next-generation sequencing and epigenome-wide profiling supported the identification of canonical mutations and epigenetic dysregulation. These methods also clarified how mutations vary by tumour location and age of onset.\"},{\"question\":\"Which genetic/epigenetic changes are highlighted as key hallmarks or driver events?\",\"answer\":\"Recurrent DNA methylation and histone mutations are emphasized as hallmarks of paediatric astrocytoma oncogenesis. Driver alterations include recurrent histone H3 mutations in high-grade tumours.\"}]","Novel insights on genetics and epigenetics as clinical targets for paediatric astrocytoma | PDF",1790019114,63,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fafb4690be79e9a6ecd0364e9d90bca8.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/96599f081c6f612af66cd5a687e61fb2.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/afaf0e0e34ef85de02acb7dc29a6ddb4.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/271958f60044e75ff1ee19c4648b323f.webp",980,1287]